Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huangshi Yanwu Pharmaceutical is a pharmaceutical manufacturing company based in Huangshi, Hubei Province, China, and is a key subsidiary of Grand Pharma (China). The company specializes in the production of chemical active pharmaceutical ingredients (APIs) and a wide range of finished dosage forms, including tablets, capsules, and granules. Its product portfolio is diverse, covering therapeutic areas such as cardiovascular disease, respiratory ailments, and pain management, with a significant emphasis on both modern chemical drugs and traditional Chinese medicine. Huangshi Yanwu Pharmaceutical operates under strict GMP standards and serves as a production base for several essential medicines distributed throughout China. The company's long-standing reputation in the region is built upon its history as the former Huangshi Pharmaceutical Factory.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huangshi Yanwu Pharmaceutical.